Brought to you by:
SVS set to take part in ACC smoking cessation webinar
The Society for Vascular Surgery (SVS) will take part in an upcoming webinar titled “Breaking the Habit, Saving Lives: The National Quality Initiative Push for Smoking Cessation” at the 2025 American College of Cardiology Quality Summit, Tuesday, Oct. 14. The…
Class of 2024–25: VQI announces third annual set of Fellowship in Training Program awardees
The Vascular Quality Initiative (VQI) Patient Safety Organization’s Fellowship in Training (FIT) Program has announced its third class of FIT participants for 2024–25 alongside the new FIT scholars. VQI FIT began in January 2022 and is designed to introduce residents…
From the editor: House of Cards
On Jan. 22, 2024, the American Heart Association (AHA) and the American College of Cardiology (ACC), together with three other major cardiology societies, submitted a proposal for the formation of the American Board of Cardiovascular Medicine. Essentially, the 157-page document…
PAD guideline update from ACC, AHA and others centers multispecialty care
New multisociety clinical practice guidelines for the management of lower extremity peripheral arterial disease (PAD) have been published online in the Journal of the American College of Cardiology (JACC). One of the document’s key takeaway messages is that care for…
SCAI issues position paper on transaxillary arterial access
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official position statement providing evidence-based recommendations for percutaneous transaxillary arterial access and training for clinicians. The document was published in the Journal of the Society for Cardiovascular Angiography &…
ACC.21: VOYAGER PAD shows rivaroxaban ‘significantly’ reduced total ischemic events in PAD patients
Rivaroxaban combined with low-dose aspirin led to a significant reduction in the occurrence of total ischemic events in patients with symptomatic peripheral arterial disease (PAD) who underwent lower-extremity revascularization, according to researchers conducting the VOYAGER PAD trial. The findings were…
SVS, ACC complete move to single vascular registry
The Society for Vascular Surgery (SVS) and the American College of Cardiology (ACC) have completed a move to create a single vascular registry. The new joint venture is designed to harness the strengths of both organizations in improving care and…
‘Ample published data unable to replicate association between paclitaxel-coated devices and mortality’
Ample published data from from large, observational datasets, randomized-controlled trial (RCT) subgroup analyses and long-term follow-up from pivotal paclitaxel-coated device RCTs have not been able to replicate an association between such devices and mortality, an expert analysis recently published online…
ACC, SVS join forces on single vascular registry
The American College of Cardiology (ACC) and Society for Vascular Surgery (SVS) are collaborating on a single vascular registry to harness the strengths of both organizations in improving care and outcomes of patients with vascular disease. The Vascular Quality Initiative…
Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularization
Treatment with aspirin plus rivaroxaban following lower-extremity revascularization in patients with peripheral arterial disease (PAD) leads to a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with aspirin alone. The VOYAGER PAD study was…